Search results

This study aims to analyze the resources used in the citations of 156 postgraduate dissertations submitted to the Rajiv Gandhi University of Health Sciences (RGUHS) through the Acharya & BM Reddy College of Pharmacy (ABMRCP), and prepares the core journal list according to the Bradford’s law of scattering. For any research and academic institutional libraries, books and journals are considered as key resources. As the resources are more and diverse, collection building is a tough task for librarians. Citation analysis is one of the best methods to list the most used resources by the users. The paper highlights the extent use of in-house resources and open access journals in the citations.

Citations of PG dissertations during 2010-2013 (four years) were compiled, the data about the resources cited in each were taken and the list of resources used in PG dissertations was prepared. The list of core journals obtained by citation analysis was matched with the list of online journals provided by Health Science Library & Information Network (HELINET) of RGUHS as well as print list of journals subscribed by ABMRCP Library, and evaluated the print and online consortia journals used by ABMRCP community. The list of core journals’ ranking in the SCImago Journal & Country Rank (SJR) list-pharmaceutical sciences was identified to know the impact of the journals.

The study gives the list of different information resources cited in the pharmacy dissertations. The core list obtained by applying the Bradford’s law of scattering in this study has 19 journals pertaining to pharmacy. After matching the core list with the Keogh’s list, it is found that 31 journals can be considered very useful in the field of pharmacy. Twelve journals listed in the core list have different positions in the SJR ranking 2013. The results indicate that open-access journals with online journals subscribed through HELINET and print holdings have been cited more in the PG dissertations.

The topic of journal use in this case may be of greatest interest to those who purchase journals in the sciences and, very specifically, the pharmaceutical sciences.

The aim of this paper is to explore and analyse the challenges in effective implementation of blockchain by human resource management (HRM) functions. This paper also aims to assess the interplay between the barriers in causing the challenges during blockchain execution.

Ten barriers are discovered from the past studies. Based on the expert views on the identified barriers interpretive structural modelling (ISM) is administered to understand the interplay of these 10 challenges resulting in ineffective or non-implementation of HR blockchain.

The application of ISM has helped in categorizing the variables into strategic, operational and performance outcomes. Results of ISM indicate key barriers like lack of expertise, data privacy, technical infeasibility, complexity in implantation and lack of used cases.

The research is limited to 10 barriers. There can be other barriers that can also be studied. Second, the research is proposing a conceptual model that needs further validation.

This paper has significant implications for the theoretical and practical body of knowledge. So far, most studies are exploring and describing HRM from a digital perspective. Most HR studies are on artificial intelligence, the Internet of Things and smart HRM. Previous studies on blockchain for HRM are mostly describing the advantages of going for it.

Based on the findings, it can also be suggested that policy formulators must advance the technical regulatory framework. Blockchain technology can be effectively implemented only if the top management is committed to it because they can only frame the rules and right control framework, affirm the governance process and strategize improvement.

The study offers insights into the organization's decision makers for effectively implementing blockchain into their HR systems. Some specific recommendations based on the results are also made. The paper is an innovative attempt to analyse the barriers to HR blockchain.

This review aims to provide synoptic documentation on acclaimed anecdotal plant-based remedies used by Latin America and the Caribbean (LAC) communities to manage COVID-19. The theoretical approaches that form the basis for using the anecdotally claimed phytotherapies were reviewed against current scientific evidence.

In this paper plant-based remedies for managing COVID-19 were searched on social and print media to identify testimonies of people from different communities in LAC countries. Information was extracted, evaluated and reviewed against current scientific evidence based on a literature search from databases such as Journal Storage (JSTOR), Excerpta Medica Database (EMBASE), SpringerLink, Scopus, ScienceDirect, PubMed, Google Scholar and Medline to explore the scientific basis for anecdotal claims.

A total of 23 medicinal plants belonging to 15 families were identified as phytotherapies used in managing COVID-19 in LAC communities.

The plant-based remedies contained valuable phytochemicals scientifically reported for their anti-inflammatory, antiviral, antioxidant and anticancer effects. Anecdotal information helps researchers investigate disease patterns, management and new drug discoveries. The identified acclaimed plant-based remedies are potential candidates for pharmacological evaluations for possible drug discovery for future pandemics.

The purpose of this study is to examine the acute toxicity and antidiabetic activity of Asystacia gangetica leaf ethanol extract.

The study was designed as completely randomized in vivo experimental model. Where acute toxicity study was carried out using 30 albino mice, randomly assigned into six groups of five mice each. Toxicity signs and mortality were observed in the rats within a period of 24 h. The acute and sub-acute antidiabetic study was carried out using 50 rats, randomly assigned into five groups of 10 rats each. The rats’ blood glucose levels were determined and used to assess the acute and sub-acute antidiabetic activity of the extract.

Results obtained from the acute toxicity study indicated no death in any of the study groups, even at 5,000 mg/kg body weight and showed no signs of toxicity. The acute antidiabetic study showed that treatment with 400 mg/kg of the extract significantly (p = 0.01) lowered glucose level in the diabetic rats from 430.6 to 177.4 mg/dl while 800 mg/kg brought down glucose level from 370 to 144.2 mg/dl by the end of 6 h following administration when compared with the diabetic control group. It was observed that the effect of the extract mostly at 800 mg/kg also compared favorably with that of the standard drug (glibenclamide), which lowered glucose level in diabetic rats from 374.2 to 176.4 mg/dl. Furthermore, the significant reduction was evident from 4, 2 and 2 h for 400 mg/kg extract, 800 mg/kg extract and 5 mg/kg glibenclamide, respectively. At sub-acute level the blood glucose was lowered from 155.6 to 127.2 mg/dl, 137 to 124.4 mg/dl and 151.8 to 121.8 mg/dl for diabetic rats treated with 400 mg/kg, 800 mg/kg and 5 mg/kg glibenclamide, respectively, when compared to the diabetic untreated rats, which ranged from 417.6 to 358.6 mg/dl. The biochemical profile, lipid profile and hematological examination were all positively restored near to normal with the herbal treatment at the different doses. At histopathology level, the liver of the rats treated with 400 mg/kg had moderate portal inflammation without interface or lobular hepatitis while that of 800 mg/kg showed severe portal inflammation with the interface and lobular hepatitis with extensive confluents necrosis. The pancreatic cells of the treated rat showed no significant difference in the β-cells of the islets of Langerhans with hyperplasia of the acinar cell when compared to the diabetic untreated.

The record of no death and signs of toxicity implies that the extract is safe for consumption even at a high dosage of 5,000 mg/kg body weight. The significant (p = 0.01) reduction in the plasma glucose level of the treated rats as compared to the control is an indication of blood glucose-lowering potential of the extract at two different doses. The significant reduction evident of the extract at different hours and days for the two doses implies that the extract rate of lowering potentials is dose-dependent. The evidence of moderate-severe portal inflammation with the interface and lobular hepatitis at 800 mg/kg treatment is an indication that the intake of this herb at high dosage for long period is not safe for the liver tissue.

The outcome of this study suggested that the Asystacia gangetica should also be used as a vegetable in-home food preparation and food processing to use its antidiabetic effect. The herbal extract could also be incorporated into a food product and processed into herbal tea bag for convenient. The subjection of this herbal plant to heat treatment during processing could be a possible avenue to make it safe.

The economic burden and complications of diabetes mellitus management will be reduced if the practical implication of this research finding is implemented in foods as vegetable and in functional food production.

This study revealed that Asystacia gangetica leaf extract may be safe and effective for use at a low dose for acute management of diabetes mellitus. This research may be of value to those living with diabetes mellitus.